SCHEMBL24254515

SCHEMBL24254515

CCc1ccc(SN(C)C)cc1NC(=O)Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HTT P42858 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
KCNQ2 O43526 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CLK1 P49759 1/20 0.43
GAA P10253 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.41
POLB P06746 1/20 0.41
PARP14 Q460N5 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254575 0.87 MAPT (0.53) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254547 0.79 MEN1 (0.58) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254497 0.79 ALDH1A1 (0.56) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254554 0.76 TSHR (0.39) MAPTKMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL24254545 0.71 SELL (0.45) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254543 0.70 MEN1 (0.56) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254523 0.70 HPGD (0.59) MAPTLMNAMEN1KMT2AHTT
SCHEMBL24254485 0.68 ALDH1A1 (0.60) MAPTLMNAMEN1KMT2AHTT
SCHEMBL8269613 0.67 KMT2A (0.65) MAPTLMNAMEN1KMT2AHTT
SCHEMBL7415754 0.67 TSHR (0.53) MAPTLMNAMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed